RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients

Transfusion

Volumn 43, Issue 11, 2003, Pages 1604-1610

  Ameen, Reem ^a   Al Shemmari, Salem ^b   Al Humood, Salah ^b   Chowdhury, Rafiq I ^b   Al Eyaadi, Ohood ^b   Al Bashir, Abdulaziz ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; ERYTHROCYTE ANTIBODY; RHESUS E ANTIBODY;

ADOLESCENT; ADULT; ALLOIMMUNIZATION; ARAB; AUTOIMMUNITY; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RH; BLOOD TRANSFUSION; CHILD; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; FEMALE; HEMOGLOBINOPATHY; HUMAN; INFANT; KUWAIT; MAJOR CLINICAL STUDY; MALE; REVIEW; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; ARABS; AUTOIMMUNITY; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION; INFANT; ISOANTIGENS; MALE; RH ISOIMMUNIZATION; THALASSEMIA;

EID: 0242440019     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2003.00549.x     Document Type: Review

References (34)

1. Weatherall DJ. The molecular basis of phenotypic diversity of genetic disease. Ann NY Acad Sci 1995;758:245-60.
2. Kazazian HH. The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. Semin Hematol 1994;27: 209-28.
3. s haplotypes among Kuwaiti Arabs. Acta Haematol 1994;92:176-81.
4. White JM, Byrne M, Richards R, et al. Red cell genetic abnormalities in Peninsular Arabs: sickle hemoglobin, G6PD deficiency and α and β thalassemia. J Med Genet 1986; 23:245-51.
5. Tebi A, Faraj T. Genetic disease among Arab population. Oxford: Oxford University Press, 1997:89.
6. Public Authority for Civil Information (PACI). Directory of civil information: regulations and labor force. Kuwait City: PACI, 2001.
7. 0 (D)? Vox Sang 1984;47:205-8.
8. Charache S. Problems in transfusion therapy (editorial). N Engl J Med 1990;322:1666-8.
9. Argiolu F, Diana G, Arnone M, et al. High dose intravenous immunoglobulin in the management of autoimmune hemolytic anemia complicating thalassemia major. Acta Hematol 1990;83:65-8.
10. Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion dependent thalassemia patients of predominantly Asian descent. Blood 2000;96:3369-73.
11. Kruatrachue M, Sirisinha S, Pacharee P, et al. An association between thalassemia and autoimmune haemolytic anaemia (AIHA). Scan J Hematol 1980;25:259-63.
12. Vengelen Tyler V, ed. Technical manual, 12th ed. Bethesda, MD: American Association of Blood Banks, 1996.
13. Hmida S, Mojaat N, Maamar M, et al. Red cell alloantibodies in patients with haemoglobinopathies. Nouv Rev Fr Hematol 1994;36:363-6.
14. Economidou J, Constantoulakis M, Augoustaki O, Adinolfi M. Frequency of antibodies to various antigenic determinants in polytransfused patients with homozygous thalassaemia in Greece. Vox Sang 1971;20:252-8.
15. Sirchia G, Zanella A, Parravicini A, et al. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion 1985;25:110-2.
16. Coles SM, Klein HG, Holland PV. Alloimmunization in two multitransfused patients populations. Transfusion 1981;21:462-6.
17. Walker RH, Lin DT, Hartrick MB. Alloimmunization following blood transfusion. Arch Pathol Lab Med 1989;113:254-61.
18. Michail-Merianou V, Pamphili-Panousopoulou L, Piperi-Lowes L, et al. Alloimmunization to red cell antigens in thalassemia: comparative study of usual versus better-match transfusion programmes. Vox Sang 1987;52:95-8.
19. Spanos T, Karageorga M, Ladis V, et al. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990;58: 50-5.
20. Ho HK, Ha SY, Lam CK, et al. Alloimmunization in Hong Kong southern Chinese transfusion dependent thalassemia patients. Blood 2001;97:3999-4000.
21. Al-Fuzae L, Aboolbacker KC, Al-Saleh Q. β-thalassaemia major in Kuwait. J Trop Pediatr 1998;44:311-2.
22. Smit Sibinga CT. Immune effects of blood transfusion. Curr Opin Hematol 1999;6:442-5.
23. Hodge G, Lloyd JV, Hodge S, et al. Functional lymphocyte immunophenotypes observed in thalassemia and hemophilia patients receiving current blood product preparations. Br J Hematol 1999;105:817-25.
24. Blajchman MA. Immunomodulatory effects of allogeneic blood transfusions: clinical manifestations and mechanisms. Vox Sang 1998;74(Suppl 2):315-9.
25. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: a possible key to explain the immunomodulatory effects of allogeneic blood transfusion. Blood 1999;93:1770-7.
26. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998;74(Suppl 2):189-200.
27. Frabetti F, Musiani D, Marini M, et al. White cell apoptosis in packed red cells. Transfusion 1998;38:1082-9.
28. Martelli AM, Tazzari PL, Bortul R, et al. Nuclear matrix protein is released from apoptotic white cells during cold (1-6 °C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. Transfusion 2000;40:169-77.
29. Pistillo MP, Tazzari PL, Gaudiano C, et al. Patients with neoplastic and nonneoplastic hematological disease acquire CTLA-4 antibodies after blood transfusion. Transfusion 2001;41:462-9.
30. Linsley PS, Brady W, Urnes M, et al. CTLA-4 is a second receptor for the cell activation antigen B7. J Exp Med 1991;174:561-9.
31. Van der Merwe PA, Bodian DL, Daenke S, et al. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med 1997;185:393-403.
32. Krummel MF, Allison JP. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 1996;183:2533-40.
33. Ness PM, Shirey RS, Thoman SK, Buck SA. The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance. Transfusion 1990;30:688-93.
34. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990;30:532-5.